Fate Therapeutics Inc (FATE)
$2.08 -4.15% Close Oct 30, 2026 Live
Fate Therapeutics stock today
Fate Therapeutics closed at $2.08 on October 30, 2026, down 4.15% on the day. Over the past year it returned +61.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $242 million.
$1.00$2.00$3.00
NovJan 2026MarMayJulSep
| Period | FATE | S&P 500 (SPY) |
|---|---|---|
| 1 month | -12.2% | -0.9% |
| 3 months | -17.1% | +2.1% |
| Year to date | +111.7% | +11.7% |
| 1 year | +61.2% | +12.4% |
| 3 years | +20.2% | +88.5% |
| 5 years | -96.1% | +76.0% |
Key statistics
- Market value
- $242M
- Price / sales
- 37.3
- 52-week range
- $0.96 to $3.11
- Next report
- Nov 12, 2026 (estimated)
About Fate Therapeutics
Develops cell therapy and immuno-oncology treatments using cell engineering technology.
Sector: Health Care
More on Fate Therapeutics
- Financials: revenue, earnings and segmentsRevenue -51% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $954.13 today
No forecast, no recommendation. This page describes Fate Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.